Appendix Cancer Overview
Learn About Appendix Cancer
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
North Atlanta Oncology Services LLC
Debra Miller is a Hematologist Oncology specialist and an Oncologist in Snellville, Georgia. Dr. Miller and is rated as an Experienced provider by MediFind in the treatment of Appendix Cancer. Her top areas of expertise are Paget Disease of the Breast, Childhood Iron Deficiency Anemia, Lung Cancer, and Pleuropulmonary Blastoma. Dr. Miller is currently accepting new patients.
Piedmont Providers LLC
Stephen Szabo is a Hematologist Oncology specialist and a Hematologist in Conyers, Georgia. Dr. Szabo and is rated as a Distinguished provider by MediFind in the treatment of Appendix Cancer. His top areas of expertise are Hereditary Neuroblastoma, Inflammatory Breast Cancer, Gastric Lymphoma, Bone Marrow Aspiration, and Colonoscopy. Dr. Szabo is currently accepting new patients.
Nsh Cancer Institute Professional Services G LLC
Ethan Tolbert is a Hematologist Oncology specialist and a Hematologist in Stockbridge, Georgia. Dr. Tolbert and is rated as a Distinguished provider by MediFind in the treatment of Appendix Cancer. His top areas of expertise are Appendix Cancer, Iron Deficiency Anemia, Colorectal Cancer, and Familial Pancreatic Cancer. Dr. Tolbert is currently accepting new patients.
Background: Cytoreductive surgery (CRS) removes tumors in the abdomen. HIPEC is heated chemotherapy that washes the abdomen. CRS and HIPEC may help people with peritoneal carcinomatosis. These are tumors that have spread to the lining of the abdomen from other cancers. Researchers think they can improve results of CRS and HIPEC by choosing the chemotherapy drugs used in HIPEC.
Summary: This is an open-label, Phase 1/2 study to determine the safety, tolerability, and efficacy of APL-5125 for the treatment of selected locally advanced or metastatic solid tumors with particular focus on Colorectal carcinoma (CRC).